PT89367A - Melhoramentos na expressao e secrecao de proteinas heterologas em levedura utilizando sequencias guias alfa-factor truncadas - Google Patents

Melhoramentos na expressao e secrecao de proteinas heterologas em levedura utilizando sequencias guias alfa-factor truncadas

Info

Publication number: PT89367A
Authority: PT; Portugal
Prior art keywords: yeast; encodes; precursor polypeptide; precursor; protein
Prior art date: 1987-12-30

Application number

PT89367A

Other languages

English (en)

Other versions

PT89367B (pt

Inventor

Patricia Tekamp-Olson

Original Assignee

Chiron Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-12-30

Filing date

1988-12-30

Publication date

1989-12-29

1988-12-30 Application filed by Chiron Corp filed Critical Chiron Corp

1989-12-29 Publication of PT89367A publication Critical patent/PT89367A/pt

1993-09-30 Publication of PT89367B publication Critical patent/PT89367B/pt

Links

240000004808 Saccharomyces cerevisiae Species 0.000 title abstract 5
108090000623 proteins and genes Proteins 0.000 title abstract 3
102000004169 proteins and genes Human genes 0.000 title abstract 2
IXKSXJFAGXLQOQ-XISFHERQSA-N WHWLQLKPGQPMY Chemical compound C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 IXKSXJFAGXLQOQ-XISFHERQSA-N 0.000 title 1
239000002243 precursor Substances 0.000 abstract 8
229920001184 polypeptide Polymers 0.000 abstract 7
108090000765 processed proteins & peptides Proteins 0.000 abstract 7
102000004196 processed proteins & peptides Human genes 0.000 abstract 7
108010058643 Fungal Proteins Proteins 0.000 abstract 5
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 4
108020004414 DNA Proteins 0.000 abstract 3
238000003776 cleavage reaction Methods 0.000 abstract 3
230000013595 glycosylation Effects 0.000 abstract 3
238000006206 glycosylation reaction Methods 0.000 abstract 3
230000007017 scission Effects 0.000 abstract 3
108091026890 Coding region Proteins 0.000 abstract 2
102000004877 Insulin Human genes 0.000 abstract 2
108090001061 Insulin Proteins 0.000 abstract 2
101150045458 KEX2 gene Proteins 0.000 abstract 2
238000001727 in vivo Methods 0.000 abstract 2
229940125396 insulin Drugs 0.000 abstract 2
102000053602 DNA Human genes 0.000 abstract 1
108010016626 Dipeptides Proteins 0.000 abstract 1
102000005593 Endopeptidases Human genes 0.000 abstract 1
108010059378 Endopeptidases Proteins 0.000 abstract 1
101000976075 Homo sapiens Insulin Proteins 0.000 abstract 1
108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract 1
102100037852 Insulin-like growth factor I Human genes 0.000 abstract 1
125000000729 N-terminal amino-acid group Chemical group 0.000 abstract 1
108010076181 Proinsulin Proteins 0.000 abstract 1
108010076504 Protein Sorting Signals Proteins 0.000 abstract 1
241000235070 Saccharomyces Species 0.000 abstract 1
150000001413 amino acids Chemical class 0.000 abstract 1
PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 abstract 1
230000028327 secretion Effects 0.000 abstract 1
230000005026 transcription initiation Effects 0.000 abstract 1
230000005030 transcription termination Effects 0.000 abstract 1
210000005253 yeast cell Anatomy 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Mycology (AREA)
Gastroenterology & Hepatology (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
General Engineering & Computer Science (AREA)
Endocrinology (AREA)
Wood Science & Technology (AREA)
Microbiology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Toxicology (AREA)
Bioinformatics & Cheminformatics (AREA)
Plant Pathology (AREA)
Physics & Mathematics (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Enzymes And Modification Thereof (AREA)

PT89367A 1987-12-30 1988-12-30 Melhoramentos na expressao e secrecao de proteinas heterologas em levedura utilizando sequencias guias alfa-factor truncadas PT89367B (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US13968287A	1987-12-30	1987-12-30

Publications (2)

Publication Number	Publication Date
PT89367A true PT89367A (pt)	1989-12-29
PT89367B PT89367B (pt)	1993-09-30

Family

ID=22487825

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT89367A PT89367B (pt)	1987-12-30	1988-12-30	Melhoramentos na expressao e secrecao de proteinas heterologas em levedura utilizando sequencias guias alfa-factor truncadas

Country Status (15)

Country	Link
US (2)	US5602034A (pt)
EP (1)	EP0324274B1 (pt)
JP (1)	JP2793215B2 (pt)
AT (1)	ATE97441T1 (pt)
AU (1)	AU616228B2 (pt)
CA (1)	CA1340772C (pt)
DE (1)	DE3885728T2 (pt)
DK (2)	DK175910B1 (pt)
ES (1)	ES2059547T3 (pt)
FI (1)	FI100995B (pt)
HK (1)	HK139994A (pt)
IE (1)	IE62087B1 (pt)
IL (1)	IL88802A0 (pt)
NO (1)	NO178829C (pt)
PT (1)	PT89367B (pt)

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5170964A (ja) *	1974-12-16	1976-06-19	Hohnen Oil	Haisuinoshoriho
NZ207842A (en)	1983-04-25	1988-02-12	Chiron Corp	Production of human insulin-like growth factor (igf) using cdna
US5010182A (en) *	1987-07-28	1991-04-23	Chiron Corporation	DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides
EP0548267A4 (en) *	1990-09-04	1994-11-23	Salk Inst Biotech Ind	Production of insulin-like growth factor-1 in methylotrophic yeast cells
US5612198A (en) *	1990-09-04	1997-03-18	The Salk Institute	Production of insulin-like growth factor-1 in methylotrophic yeast cells
ATE177472T1 (de) *	1990-09-14	1999-03-15	Chiron Corp	Expression von makrophagen-induzierbaren proteinen (mips) in hefezellen
ATE158816T1 (de)	1990-11-26	1997-10-15	Genetics Inst	Expression von pace in wirtszellen und verfahren zu dessen verwendung
DK300090D0 (da) *	1990-12-19	1990-12-19	Novo Nordisk As	Fremgangsmaade til fremstilling af leadersekvenser
ATE220105T1 (de) *	1991-04-01	2002-07-15	Merck & Co Inc	Gene, die die proteolytische aktivitaet von pichia beeinflussen und deren verwendung
US6348327B1 (en)	1991-12-06	2002-02-19	Genentech, Inc.	Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells
DK0682710T3 (da) *	1993-02-10	2004-03-01	Unilever Nv	Isolationsmetode, ved hvilken der anvendes immobiliserede proteiner med specifikke kapaciteter
US5538863A (en) *	1993-07-01	1996-07-23	Immunex Corporation	Expression system comprising mutant yeast strain and expression vector encoding synthetic signal peptide
US6451562B1 (en)	1993-12-22	2002-09-17	Human Genome Sciences, Inc.	Polypeptides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) polynucleotides
US6495129B1 (en)	1994-03-08	2002-12-17	Human Genome Sciences, Inc.	Methods of inhibiting hematopoietic stem cells using human myeloid progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3)
US5629167A (en)	1994-04-19	1997-05-13	Biocine S.P.A.	Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay
RU2167939C2 (ru) *	1994-06-16	2001-05-27	Ново Нордиск А/С	Способ продуцирования полипептида в дрожжах
US5639642A (en) *	1994-06-16	1997-06-17	Novo Nordisk A/S	Synthetic leader peptide sequences
US6500645B1 (en)	1994-06-17	2002-12-31	Novo Nordisk A/S	N-terminally extended proteins expressed in yeast
IL114160A (en) *	1994-06-17	2006-12-31	Novo Nordisk As	Dna constructs encoding heterologous proteins and processes for the heterologous protein production in yeast
HRP940432B1 (en) *	1994-08-05	2003-10-31	Pliva Pharm & Chem Works	Dna sequences encoding biosynthetic insulin precursors and process for preparation of insulin
EP0779927A1 (en) *	1994-09-08	1997-06-25	Chiron Corporation	A method of improved production of insulin-like growth factor
GB9513967D0 (en) *	1995-07-08	1995-09-06	Univ Leicester	Insulin
ZA9610456B (en) *	1995-12-20	1997-06-20	Novo Nordisk As	N-terminally extended proteins expressed in yeast
AU733007B2 (en) *	1996-09-24	2001-05-03	Cadus Pharmaceutical Corporation	Methods and compositions for identifying receptor effectors
AU4977697A (en)	1996-09-25	1998-04-17	Vanderbilt University	Genetically engineered yeast with modified signal peptidase complex
EP1935901A1 (en) *	1996-12-13	2008-06-25	Novartis Vaccines and Diagnostics, Inc.	Analysis and separation of platelet-derived growth factor proteins
KR100381494B1 (ko) *	1997-06-30	2003-07-22	바이오 테크놀로지 제네랄 코오포레이션	인간인슐린의제조방법
US6068993A (en) *	1997-07-02	2000-05-30	Biobras Sa	Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
JP2001512684A (ja)	1997-08-05	2001-08-28	カイロンコーポレイション	新規のｐｉｃｈｉａｐａｓｔｏｒｉｓ遺伝子配列およびそれらの使用方法
CA2671261A1 (en)	1997-11-06	1999-05-20	Novartis Vaccines And Diagnostics S.R.L.	Neisserial antigens
EP1047784B2 (en)	1998-01-14	2015-03-18	Novartis Vaccines and Diagnostics S.r.l.	Neissera meningitidis antigens
AU2149899A (en) *	1998-01-23	1999-08-09	Novo Nordisk A/S	Process for making desired polypeptides in yeast
GB9808932D0 (en)	1998-04-27	1998-06-24	Chiron Spa	Polyepitope carrier protein
EP2261338A3 (en)	1998-05-01	2012-01-04	Novartis Vaccines and Diagnostics, Inc.	Neisseria meningitidis antigens and compositions
AU5504999A (en) *	1998-07-20	2000-02-14	Frenken, Leon Gerardus Joseph	Production of proteins
DE69932247T2 (de)	1998-08-21	2007-05-31	Immunex Corp., Thousand Oaks	Menschliches il-1 epsilon dna und polypeptide
WO2000066741A2 (en)	1999-04-30	2000-11-09	Chiron S.P.A.	Conserved neisserial antigens
GB9911683D0 (en)	1999-05-19	1999-07-21	Chiron Spa	Antigenic peptides
GB9916529D0 (en)	1999-07-14	1999-09-15	Chiron Spa	Antigenic peptides
JP2004508801A (ja)	1999-10-29	2004-03-25	カイロン　ソチエタ　ア　レスポンサビリタ　リミタータ	ナイセリア抗原性ペプチド
PT2289545T (pt)	2000-01-17	2016-09-06	Glaxosmithkline Biologicals Sa	Vacina de omv suplementada contra meningococos
DE60120372T2 (de)	2000-03-24	2007-07-05	Genentech Inc., San Francisco	Verwendung von insulin zur behandlung von knorpelkrankheiten
US6605450B1 (en)	2000-05-25	2003-08-12	Chiron Corporation	Iron regulation of the PpSEC10 transcriptional regulatory region of Pichia pastoris and methods of use
US7132273B1 (en)	2000-07-26	2006-11-07	Korea Research Institute Of Bioscience And Biotechnology	Cell wall anchor proteins derived from yeast, genes thereof and cell surface expression systems using the same
CA2881568C (en)	2000-10-27	2019-09-24	Novartis Vaccines And Diagnostics, Inc.	Nucleic acids and proteins from streptococcus groups a & b
GB0107658D0 (en)	2001-03-27	2001-05-16	Chiron Spa	Streptococcus pneumoniae
GB0107661D0 (en)	2001-03-27	2001-05-16	Chiron Spa	Staphylococcus aureus
KR101054735B1 (ko) *	2001-07-06	2011-08-05	잇판자이단호진 가가쿠오요비겟세이료호겐쿠쇼	유전자 재조합 에카린 및 그를 제조하는 방법
RU2331435C2 (ru)	2001-12-12	2008-08-20	Чирон Срл.	Иммунизация против chlamydia trachomatis
AU2003243316A1 (en) *	2002-05-24	2003-12-12	Nps Allelix Corp.	Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
DK1521767T3 (da) *	2002-05-24	2010-04-12	Medtronic Inc	Fremgangsmåder og konstrukter til ekspression af clostripain med højt udbytte
WO2004024885A2 (en)	2002-09-13	2004-03-25	Cornell Research Foundation, Inc.	Using mutations to improve aspergillus phytases
EP1562982B1 (en)	2002-11-15	2010-05-05	Novartis Vaccines and Diagnostics S.r.l.	Unexpected surface proteins in neisseria meningitidis
GB0308198D0 (en)	2003-04-09	2003-05-14	Chiron Srl	ADP-ribosylating bacterial toxin
EP2133362B1 (en)	2003-07-25	2012-04-18	Amgen, Inc	Methods relating to LDCAM and CRTAM
HRP20120315T1 (hr) *	2003-11-21	2012-05-31	Nps Pharmaceuticals	Proizvodnja peptida 2 nalik glukagonu i analoga
WO2005055944A2 (en)	2003-12-05	2005-06-23	Cincinnati Children's Hospital Medical Center	Oligosaccharide compositions and use thereof in the treatment of infection
BRPI0507169A (pt)	2004-02-02	2007-06-26	Ambrx Inc	polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos
US7632924B2 (en) *	2004-06-18	2009-12-15	Ambrx, Inc.	Antigen-binding polypeptides and their uses
WO2006091231A2 (en) *	2004-07-21	2006-08-31	Ambrx, Inc.	Biosynthetic polypeptides utilizing non-naturally encoded amino acids
CN103520735B (zh) *	2004-12-22	2015-11-25	Ambrx公司	包含非天然编码的氨基酸的人生长激素配方
BRPI0519430A2 (pt)	2004-12-22	2009-02-10	Ambrx Inc	hormânio do crescimento humano modificado
EP2399893B1 (en)	2004-12-22	2018-08-15	Ambrx, Inc.	Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
EP1836316A4 (en)	2004-12-22	2009-07-22	Ambrx Inc	PROCESS FOR EXPRESSION AND CLEANING OF RECOMBINANT HUMAN GROWTH HORMONE
EP1836298B1 (en) *	2004-12-22	2012-01-18	Ambrx, Inc.	COMPOSITIONS OF AMINOACYL-tRNA SYNTHETASE AND USES THEREOF
WO2006132925A2 (en)	2005-06-01	2006-12-14	University Of Pittsburgh Of The Commonwealth System Of Higher Education	Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy
AU2006255122B2 (en) *	2005-06-03	2010-10-21	Ambrx, Inc.	Improved human interferon molecules and their uses
AU2005335491B2 (en)	2005-08-18	2010-11-25	Ambrx, Inc.	Compositions of tRNA and uses thereof
CN101400646A (zh) *	2005-11-08	2009-04-01	Ambrx公司	用于修饰非天然氨基酸和非天然氨基酸多肽的促进剂
DK2339014T3 (en)	2005-11-16	2015-07-20	Ambrx Inc	Methods and compositions comprising non-natural amino acids
WO2007070659A2 (en) *	2005-12-14	2007-06-21	Ambrx, Inc.	Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
PT2054431E (pt)	2006-06-09	2011-11-03	Novartis Ag	Confórmeros de adesinas bacterianas
CN106008699A (zh) *	2006-09-08	2016-10-12	Ambrx公司	经修饰的人类血浆多肽或Fc骨架和其用途
JP5399906B2 (ja) *	2006-09-08	2014-01-29	アンブルックス，インコーポレイテッド	脊椎動物細胞用のハイブリッドサプレッサーｔｒｎａ
EP2064333B1 (en) *	2006-09-08	2014-02-26	Ambrx, Inc.	Suppressor trna transcription in vertebrate cells
WO2008032659A1 (fr) *	2006-09-14	2008-03-20	National Institute Of Advanced Industrial Science And Technology	Peptide signal de sécrétion doté d'une efficacité améliorée, et procédé de production de protéine au moyen dudit peptide
CN107501407B (zh)	2007-03-30	2022-03-18	Ambrx公司	经修饰fgf-21多肽和其用途
US8114630B2 (en)	2007-05-02	2012-02-14	Ambrx, Inc.	Modified interferon beta polypeptides and their uses
MX2010005317A (es)	2007-11-20	2010-06-02	Ambrx Inc	Polipeptidos de insulina modificados y sus usos.
MX344166B (es)	2008-02-08	2016-12-07	Ambrx Inc	Leptina-polipeptidos modificados y sus usos.
CN102159230A (zh)	2008-07-23	2011-08-17	Ambrx公司	经修饰的牛g-csf多肽和其用途
AU2009296267B2 (en)	2008-09-26	2013-10-31	Ambrx, Inc.	Non-natural amino acid replication-dependent microorganisms and vaccines
BR122012024318A2 (pt)	2008-09-26	2019-07-30	Ambrx, Inc.	Polipeptídeos modificados de eritropoetina animal e seus usos
EP2258855A1 (en)	2009-05-28	2010-12-08	Universität für Bodenkultur Wien	Expression sequences
EP2494050A4 (en) *	2009-10-30	2013-10-30	Merck Sharp & Dohme	GRANULOCYTIC COLONY STIMULATING FACTOR MADE IN GLYCOENGINEERED PICHIA PASTORIS
MX349301B (es)	2009-12-21	2017-07-21	Ambrx Inc	Polipéptidos de somatotropina bovina modificados y sus usos.
BR112012015597A2 (pt)	2009-12-21	2017-01-31	Ambrx Inc	peptídeos de somatotropina suínos modificados e seus usos
EA030886B1 (ru)	2010-08-17	2018-10-31	Амбркс, Инк.	Модифицированные полипептиды релаксина, содержащие некодируемую в природе аминокислоту, связанную с полимером, и их применение
US9567386B2 (en)	2010-08-17	2017-02-14	Ambrx, Inc.	Therapeutic uses of modified relaxin polypeptides
TWI480288B (zh)	2010-09-23	2015-04-11	Lilly Co Eli	牛顆粒細胞群落刺激因子及其變體之調配物
WO2013016220A1 (en)	2011-07-22	2013-01-31	Amgen Inc.	Il-17 receptor a is required for il-17c biology
KR102079293B1 (ko)	2012-10-29	2020-02-19	론자 리미티드	발현 서열
EP2999712B1 (en)	2013-04-30	2018-11-21	Donald Danforth Plant Science Center	Antifungal plant proteins, peptides, and methods of use
WO2015128507A1 (en)	2014-02-28	2015-09-03	Novo Nordisk A/S	Mating factor alpha pro-peptide variants
CN114805532A (zh)	2014-10-24	2022-07-29	百时美施贵宝公司	修饰的fgf-21多肽及其用途
PE20191716A1 (es)	2017-02-08	2019-12-05	Bristol Myers Squibb Co	Polipeptidos de relaxina modificada que comprenden un mejorador farmacocinetico y sus usos
CN111094572B (zh) *	2018-02-09	2023-04-04	江苏恒瑞医药股份有限公司	一种密码子优化的人胰岛素类似物前体基因和信号肽基因
US20210388037A1 (en)	2018-11-19	2021-12-16	Basf Se	Leader sequence for yeast
CN110028562B (zh) *	2019-04-25	2023-03-03	福州量衍科技有限公司	优化的Komagataella pastoris酵母α-factor信号肽及应用
US12331302B2 (en)	2019-11-08	2025-06-17	The Regents Of The University Of California	Fungal autoinducible expression system
BR102019026867A2 (pt) *	2019-12-16	2021-06-29	Petróleo Brasileiro S.A. - Petrobras	Microrganismos geneticamente modificados que realizam a produção heteróloga de versões modificadas da proteína surfactante lv-ranaspumina-1 (lv-rsn-1), as versões modificadas dessa proteína surfactante, os genes sintéticos que codificam essa proteína surfactante, os cassetes de expressão contendo esses genes sintéticos, e os vetores de expressão contendo esses genes sintéticos
WO2026009000A1 (en)	2024-07-04	2026-01-08	Solasta Bio Limited	Methods for production of insecticidal neuropeptides

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4366246A (en)	1977-11-08	1982-12-28	Genentech, Inc.	Method for microbial polypeptide expression
IL63270A0 (en)	1980-08-05	1981-10-30	Univ Leland Stanford Junior	Eukaryotic autonomously replicating segment
US4775622A (en) *	1982-03-08	1988-10-04	Genentech, Inc.	Expression, processing and secretion of heterologous protein by yeast
US4546082A (en) *	1982-06-17	1985-10-08	Regents Of The Univ. Of California	E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins
EP0116201B1 (en)	1983-01-12	1992-04-22	Chiron Corporation	Secretory expression in eukaryotes
CA1341302C (en)	1983-02-22	2001-10-09	Rae Lyn Burke	Yeast expression systems with vectors having gapdh or pyk promoters and synthesis of foreign protein
JPS60501140A (ja) *	1983-04-22	1985-07-25	アムジエン	酵母による外因性ポリペプチドの分泌
US4546083A (en)	1983-04-22	1985-10-08	Stolle Research & Development Corporation	Method and device for cell culture growth
NZ207926A (en) *	1983-04-25	1988-04-29	Genentech Inc	Use of yeast #a#-factor to assist in expression of proteins heterologus to yeast
NZ207842A (en) *	1983-04-25	1988-02-12	Chiron Corp	Production of human insulin-like growth factor (igf) using cdna
US4870008A (en) *	1983-08-12	1989-09-26	Chiron Corporation	Secretory expression in eukaryotes
ATE102250T1 (de)	1984-05-11	1994-03-15	Chiron Corp	Erhoehte hefetranskription unter verwendung einer hybridkonstruktion der promotorregion.
JPS6156078A (ja) *	1984-07-27	1986-03-20	Suntory Ltd	酵母を宿主とする分泌発現ベクタ−
WO1986001515A1 (en) *	1984-08-29	1986-03-13	Chiron Corporation	Expression of human connective tissue activator and related peptides
DK129385A (da) *	1985-03-22	1986-09-23	Novo Industri As	Peptider og fremstilling deraf
JPS6236183A (ja)	1985-06-20	1987-02-17	ザ・サルク・インステイチユ−ト・バイオテクノロジ−／インダストリアル・アソシエイツ・インコ−ポレ−テツド	サツカロミセス・セレビシエからのポリペプチドの発現および分泌
PH25772A (en) *	1985-08-30	1991-10-18	Novo Industri As	Insulin analogues, process for their preparation
US5010182A (en)	1987-07-28	1991-04-23	Chiron Corporation	DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides
EP0387319B1 (en) *	1988-07-23	1996-03-06	Delta Biotechnology Limited	Secretory leader sequences

1988
- 1988-12-22 CA CA000586916A patent/CA1340772C/en not_active Expired - Fee Related
- 1988-12-23 ES ES88312306T patent/ES2059547T3/es not_active Expired - Lifetime
- 1988-12-23 DE DE88312306T patent/DE3885728T2/de not_active Expired - Lifetime
- 1988-12-23 EP EP88312306A patent/EP0324274B1/en not_active Expired - Lifetime
- 1988-12-23 AT AT88312306T patent/ATE97441T1/de not_active IP Right Cessation
- 1988-12-26 IL IL88802A patent/IL88802A0/xx unknown
- 1988-12-28 FI FI886008A patent/FI100995B/fi not_active IP Right Cessation
- 1988-12-28 NO NO885786A patent/NO178829C/no unknown
- 1988-12-29 DK DK198807285A patent/DK175910B1/da not_active IP Right Cessation
- 1988-12-30 AU AU27650/88A patent/AU616228B2/en not_active Expired
- 1988-12-30 PT PT89367A patent/PT89367B/pt not_active IP Right Cessation
- 1988-12-30 IE IE389688A patent/IE62087B1/en not_active IP Right Cessation
- 1988-12-30 JP JP63335685A patent/JP2793215B2/ja not_active Expired - Lifetime
1994
- 1994-09-27 US US08/313,540 patent/US5602034A/en not_active Ceased
- 1994-12-08 HK HK139994A patent/HK139994A/en not_active IP Right Cessation
1998
- 1998-08-27 US US09/140,858 patent/USRE37343E1/en not_active Expired - Lifetime
2005
- 2005-01-27 DK DK200500130A patent/DK176075B1/da not_active IP Right Cessation

Also Published As

Publication number	Publication date
NO178829B (no)	1996-03-04
DK728588A (da)	1989-07-01
DK200500130A (da)	2005-01-27
HK139994A (en)	1994-12-16
DE3885728D1 (de)	1993-12-23
EP0324274B1 (en)	1993-11-18
AU2765088A (en)	1989-07-06
FI886008L (fi)	1989-07-01
CA1340772C (en)	1999-09-28
EP0324274A1 (en)	1989-07-19
NO885786D0 (no)	1988-12-28
NO885786L (no)	1989-07-03
IE62087B1 (en)	1994-12-14
JPH022339A (ja)	1990-01-08
IL88802A0 (en)	1989-07-31
ATE97441T1 (de)	1993-12-15
AU616228B2 (en)	1991-10-24
FI100995B (fi)	1998-03-31
US5602034A (en)	1997-02-11
USRE37343E1 (en)	2001-08-28
PT89367B (pt)	1993-09-30
ES2059547T3 (es)	1994-11-16
DK728588D0 (da)	1988-12-29
NO178829C (no)	1996-06-12
DE3885728T2 (de)	1994-03-10
IE883896L (en)	1989-06-30
DK175910B1 (da)	2005-06-13
JP2793215B2 (ja)	1998-09-03
DK176075B1 (da)	2006-04-10

Legal Events

Date

Code

Title

Description

1993-09-30

FG3A

Patent granted, date of granting

Effective date: 19930317

2008-02-26

PD4A

Change of proprietorship

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC., US

Effective date: 20080215

2009-01-12

MM4A

Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20081230

Publication	Publication Date	Title
PT89367A (pt)	1989-12-29	Melhoramentos na expressao e secrecao de proteinas heterologas em levedura utilizando sequencias guias alfa-factor truncadas
NZ232742A (en)	1991-10-25	Yeast heterologous protein production method, vectors, dna constructs and proteins so produced and aprotinin (1-58) so produced
KR880014110A (ko)	1988-12-22	인체 프로아포지방단백질 a-i의 발현
DE3583824D1 (de)	1991-09-26	Vorlaeufer des insulins, verfahren zu seiner herstellung und verfahren zur herstellung von humaninsulin aus solchen vorlaeufern des insulins.
GB2008123A (en)	1979-05-31	Method of means for microbial polypeptide expression
DE3584053D1 (de)	1991-10-17	Gentechnologisches verfahren zur herstellung von hirudinen und mittel zur durchfuehrung dieses verfahrens.
DE69434909D1 (de)	2007-02-15	Herstellung von humaninsulin
KR910021477A (ko)	1991-12-20	인체 단백질 c의 글리코실화 돌연변이체의 발현을 위한 벡터 및 화합물
KR900700500A (ko)	1990-08-13	재조합 유전자 기술에 의한 에라스타제 억제 폴리펩티드 제조방법 및 에라스타제 억제 폴리펩티드
JPS646219A (en)	1989-01-10	Peptide having promoting action on activation of protein c by thrombin
HUT52551A (en)	1990-07-28	Process for production of neutrophil-activizating factor
AU7873798A (en)	1998-07-17	N-terminally extended proteins expressed in yeast
EP0070632A2 (en)	1983-01-26	Recombinant plasmids encoded for human preproinsulin and their use in producing human insulin
NO971110L (no)	1997-05-07	Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipin
SK97195A3 (en)	1996-02-07	Dnk - sequences coding the new biosynthetic precursors of insulin and method of insuline preparation
EP0232107A3 (en)	1988-04-27	Human lymphotoxin polypeptide derivative
KR860006484A (ko)	1986-09-11	단백질 또는 당단백질의 제조방법
Zoltobrocki et al.	1985	Human Insulin–Chemistry, Biological
KR890002395A (ko)	1989-04-10	인터루킨-2 활성을 갖는 폴리펩타이드